Cissus Quadrangullaris (500mg) - Benefits, Dosage, Side Effects.

Cissus quadrangularis capsules are a standardised plant-derived nutritional supplement formulated from the dried extract of Cissus quadrangularis stem. Clinical research supports its use for bone fracture recovery, joint and ligament support, weight management, and reduction of musculoskeletal discomfort. The standardised extract contains active phytochemical constituents including ketosterones, idarubicin analogues, and ascorbic acid. The standard supplemental dose ranges from 500mg to 1,000mg per capsule, taken one to three times daily depending on the indication. It is not a pharmaceutical drug and does not replace prescription medical therapy.

What Are Cissus Quadrangularis Capsules?

Cissus quadrangularis capsules are an encapsulated dietary supplement manufactured from a standardised dry extract of the stem of the Cissus quadrangularis plant — a succulent vine belonging to the Vitaceae (grape) family. The extract is standardised to specific concentrations of biologically active constituents, primarily ketosterones (anabolic steroidal compounds naturally present in the plant), ascorbic acid (vitamin C), carotenoids, and triterpenoids.

The capsule form delivers a concentrated, measured dose of the standardised extract, ensuring consistency across production batches. Commercially available products are typically standardised to contain 40% ketosterones by dry weight, though standardisation methods vary between manufacturers. Products are available as single-ingredient supplements and in combination formulations with collagen, calcium, vitamin D3, glucosamine, or boswellic acid extract for targeted musculoskeletal applications.

Cissus quadrangularis extract is regulated as a dietary supplement in the United States under the Dietary Supplement Health and Education Act (DSHEA), and as a food supplement or nutraceutical in the European Union and India. It is not classified as a pharmaceutical drug in any major regulatory jurisdiction and therefore does not require a prescription for purchase or use.

What Are Cissus Quadrangularis Capsules Used For? 

Cissus quadrangularis capsules are used across several clinical and nutritional contexts, supported by peer-reviewed research, controlled trials, and post-market observational data.

Evidence-Supported Applications:

• Fracture healing and bone regeneration — the most extensively studied application; clinical trials demonstrate accelerated radiological and histological bone healing in closed fractures, attributed to the anabolic ketosterone constituents that promote osteoblast activity and calcium deposition at fracture sites
• Osteoporosis and bone mineral density support — supplementation has been associated with improved bone mineral density markers in postmenopausal women and elderly populations in controlled studies
• Joint and connective tissue recovery — used by athletes and post-surgical patients to support ligament, tendon, and cartilage repair; evidence points to upregulation of collagen synthesis and reduction of matrix metalloproteinase activity
• Musculoskeletal pain and inflammation — controlled studies demonstrate statistically significant reductions in joint pain scores, morning stiffness, and functional disability in subjects with osteoarthritis and exercise-induced joint stress
• Metabolic syndrome and weight management — randomised controlled trials using a proprietary extract (Cylaris/Cissus RX) showed significant reductions in body weight, waist circumference, fasting blood glucose, and lipid parameters in overweight and obese subjects
• Gastrointestinal mucosal protection — in vitro and animal studies demonstrate gastroprotective activity, with preliminary human data supporting use in peptic ulcer and gastric erosion contexts

Investigational and Emerging Applications:

• Adjunct support in stress fracture rehabilitation in athletic populations
• Post-menopausal bone loss mitigation in combination with calcium and vitamin D3
• Adjunct support in non-alcoholic fatty liver disease (NAFLD) management (early-phase data only)

How Do Cissus Quadrangularis Capsules Work? 

Cissus quadrangularis extract exerts its biological effects through multiple documented pharmacological mechanisms acting across bone, connective tissue, metabolic, and inflammatory pathways.

Step-by-step mechanistic action:

1. Gastrointestinal absorption: After oral ingestion, the lipid-soluble ketosterone constituents and water-soluble ascorbic acid fractions are absorbed across the intestinal mucosa. Bioavailability is enhanced when the capsule is taken with a meal containing dietary fat, which facilitates micellar solubilisation of fat-soluble components.
2. Anabolic steroid receptor interaction: The naturally occurring ketosterone compounds in Cissus quadrangularis have structural homology with anabolic steroids. They interact with androgen-related receptor pathways to stimulate osteoblast proliferation (bone-forming cell activity), accelerate callus formation at fracture sites, and promote net bone matrix deposition — without the systemic androgenic side effects associated with synthetic anabolic steroids at pharmacological doses.
3. Collagen biosynthesis stimulation: Ascorbic acid and triterpenoid fractions activate prolyl hydroxylase and lysyl hydroxylase enzymes critical to collagen crosslinking and maturation in connective tissue including cartilage, ligaments, tendons, and periosteum. This supports structural integrity and tensile strength during tissue repair.
4. Cyclooxygenase (COX) and lipoxygenase (LOX) inhibition: In vitro and animal studies confirm that Cissus quadrangularis extract inhibits both COX-1/COX-2 and 5-LOX enzyme pathways — the primary biochemical routes for prostaglandin and leukotriene synthesis respectively. This dual inhibition produces anti-inflammatory and analgesic effects mechanistically comparable to non-steroidal anti-inflammatory drugs (NSAIDs), though with a significantly lower gastrointestinal risk profile.
5. Osteocalcin and bone-specific alkaline phosphatase (BSAP) upregulation: Clinical studies report statistically significant increases in osteocalcin and BSAP — two validated biomarkers of active bone formation — following 8–12 weeks of standardised Cissus quadrangularis supplementation. These markers confirm biological anabolic activity at the bone tissue level.
6. Adipogenesis inhibition and lipid metabolism modulation: In weight management studies, Cissus quadrangularis extract has been shown to inhibit the differentiation of pre-adipocytes into mature fat cells (adipogenesis), reduce pancreatic lipase activity (limiting dietary fat absorption), and downregulate lipogenic gene expression in hepatic tissue.
7. Antioxidant activity: The carotenoid and ascorbic acid content confers measurable free radical scavenging activity, reducing oxidative stress in inflamed periarticular and osseous tissue — a contributing factor to cartilage degradation in degenerative joint conditions.

Cissus Quadrangularis Capsules Dosage Guide

Important: Dosages above are based on published clinical trial protocols and standard supplement labelling. Individual requirements may vary. Always follow the specific dosing instructions on the product label or as directed by a qualified healthcare practitioner. Consult your physician before starting supplementation if you have any pre-existing medical condition or are taking prescription medications.

Side Effects of Cissus Quadrangularis Capsules

Common Side Effects

• Mild gastrointestinal discomfort — nausea, bloating, or loose stools, particularly when taken on an empty stomach
• Dry mouth in a small percentage of users
• Mild headache reported in early weeks of supplementation — typically transient
• Increased bowel frequency in high-dose protocols (above 2,000mg/day)

Less Common Side Effects

• Skin rash or mild urticarial reaction — rare; discontinue and review if persistent
• Mild hormonal sensitivity symptoms (theoretical, related to ketosterone content) — no clinically confirmed androgenic side effects reported at standard supplemental doses in published human trials
• Insomnia when taken in the evening — take earlier in the day if this occurs

Precautionary Considerations

• Hormonal conditions: Due to the structural similarity of ketosterones to steroidal compounds, individuals with hormone-sensitive conditions (e.g., hormone-receptor-positive cancers, polycystic ovary syndrome, endometriosis) should consult an endocrinologist or oncologist before use.
• Pregnancy and lactation: Insufficient safety data exists for use during pregnancy or breastfeeding. Avoid use in these populations unless explicitly directed by a qualified medical practitioner.
• Pre-operative use: Discontinue at least 2 weeks before elective surgery due to theoretical effects on bone metabolism and potential interaction with anaesthetic agents.Note: Cissus quadrangularis capsules are not a pharmaceutical drug and are not associated with Black Box Warnings. However, supplementation should be discussed with a qualified healthcare provider in the context of any existing medical condition or concurrent prescription medication use.

Storage and Handling

• Store at controlled room temperature: 15°C to 30°C
• Protect from moisture, direct heat, and prolonged light exposure
• Keep in original manufacturer's sealed container
• Store out of reach of children
• Do not use beyond the printed expiry date
• Dispose of expired product through appropriate pharmaceutical take-back or safe waste disposal channels

Frequently Asked Questions

What are Cissus quadrangularis capsules used for?

Cissus quadrangularis capsules are a standardised dietary supplement used primarily for fracture healing acceleration, bone mineral density support, joint and ligament recovery, musculoskeletal pain reduction, and metabolic management in overweight individuals. The supplement's active ketosterone constituents promote osteoblastic bone-forming activity, while its COX and LOX inhibitory fractions reduce inflammatory mediator production in periarticular and osseous tissue. It is used by orthopaedic patients, athletes, and individuals managing degenerative joint conditions as an adjunct to conventional medical treatment.

How long does Cissus quadrangularis take to work?

Clinically measurable effects from Cissus quadrangularis supplementation typically become detectable within 4 to 8 weeks of consistent daily use. In fracture healing studies, radiological evidence of accelerated callus formation has been documented from week 4 onwards. For joint pain reduction, statistically significant improvements in visual analogue scale (VAS) pain scores are generally reported by week 6 to 8. Weight management studies demonstrated measurable body composition changes at 8 weeks. Optimal outcomes require sustained supplementation over a minimum of 8 to 12 weeks.

Can Cissus quadrangularis capsules be taken with other bone supplements?

Yes, Cissus quadrangularis is commonly combined with calcium carbonate or citrate, vitamin D3, magnesium, and collagen peptides for enhanced bone support protocols. It is also frequently formulated alongside glucosamine sulphate or boswellic acid extract for comprehensive joint support. There are no documented pharmacokinetic interactions between Cissus quadrangularis extract and these nutritional co-supplements. Combination with prescription bisphosphonates (e.g., alendronate, risedronate) or hormone replacement therapy should be discussed with the treating physician before initiation.

Are Cissus quadrangularis capsules safe for long-term use?

Published clinical trials extending up to 10 weeks have reported a favourable safety profile with adverse event rates below 5%, predominantly mild gastrointestinal symptoms. Long-term safety data beyond 6 months in controlled human studies is currently limited. Based on available evidence, standardised Cissus quadrangularis extract at doses of 500mg to 2,000mg per day appears well tolerated for short-to-medium term use. For supplementation extending beyond 3 to 6 months, periodic clinical review including liver function tests and relevant hormonal markers is advisable as a precautionary measure.

Can Cissus quadrangularis capsules help with weight loss?

Randomised controlled trials using a standardised Cissus quadrangularis extract (proprietary blend) demonstrated statistically significant reductions in body weight (approximately 3.5 kg greater than placebo at 8 weeks), waist circumference, fasting blood glucose, and plasma lipid parameters in overweight adults with metabolic syndrome. The proposed mechanisms include inhibition of pancreatic lipase activity (reducing dietary fat absorption), suppression of pre-adipocyte differentiation into mature adipocytes, and modulation of lipogenic gene expression. These results apply specifically to the studied standardised extract at the trialled doses; not all commercial products use equivalent standardisation.

Who should not take Cissus quadrangularis capsules?

Cissus quadrangularis capsules should be avoided or used only under medical supervision by: pregnant or breastfeeding women (insufficient safety data); individuals with hormone-sensitive conditions including hormone-receptor-positive malignancies or active endocrine disorders; patients scheduled for surgery within 2 weeks; individuals with known hypersensitivity to Vitaceae family plants; and patients on anticoagulant therapy (warfarin, heparin) or anti-diabetic medications without physician review, due to theoretical additive effects on glucose and lipid metabolism.

What is the difference between standardised and non-standardised Cissus quadrangularis extract?

Standardised extract refers to a manufacturing process in which the final capsule product is quality-controlled and certified to contain a defined minimum percentage of specific active constituents — most commonly 40% ketosterones in pharmaceutical-grade products. This ensures consistent potency, reproducibility of clinical effects, and batch-to-batch reliability. Non-standardised (crude) extract powders contain variable and unverified levels of active compounds, making it impossible to replicate clinical trial dosing with confidence. For therapeutic purposes aligned with published research, only standardised extracts should be selected.

Contraindications — Who Should Not Take Cissus Quadrangularis Capsules?

• Pregnant women or those who are breastfeeding — no adequate safety data available
• Individuals with hormone-sensitive oncological conditions — ketosterone content warrants oncologist review
• Patients with documented hypersensitivity to Cissus quadrangularis or Vitaceae family plant derivatives
• Patients scheduled for elective surgery within 14 days — discontinue prior to procedure
• Patients with severe hepatic impairment — limited data; exercise caution and monitor liver enzymes
• Children under 18 years — safety and dosing not established in paediatric populations

For Further More Information:  

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +918824175417, +919982524671

Buy Now